ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ADAG Adagene Inc

2.1601
-0.0199 (-0.91%)
Last Updated: 16:03:19
Delayed by 15 minutes
Name Symbol Market Type
Adagene Inc NASDAQ:ADAG NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  -0.0199 -0.91% 2.1601 2.16 2.30 2.2712 2.15 2.15 8,413 16:03:19

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

29/09/2023 11:30am

Edgar (US Regulatory)


 

  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of September 2023

 

Commission File Number: 001-39997

 

 

 

Adagene Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

4F, Building C14, No. 218

Xinghu Street, Suzhou Industrial Park

Suzhou, Jiangsu Province, 215123

People’s Republic of China

+86-512-8777-3632

(Address of principal executive offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x   Form 40-F o

 

 

 

 

 

Departure of Chief Technology Officer

 

Effective September 28, 2023, Fangyong (Felix) Du, Ph.D, Chief Technology Officer at Adagene since 2020, has resigned from Adagene to pursue other interests while serving as a part-time consultant for the Company. The resignation of Dr. Du was not due to any disagreement between Dr. Du and the Company. Adagene is appreciative of Dr. Du's service and contributions to the Company.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Adagene Inc.
     
  By: /s/ Peter (Peizhi) Luo
  Name: Peter (Peizhi) Luo
  Title: Chief Executive Officer
   
Date: September 29, 2023  

 

2

 


1 Year Adagene Chart

1 Year Adagene Chart

1 Month Adagene Chart

1 Month Adagene Chart

Your Recent History

Delayed Upgrade Clock